C91.32

Clinical Causes: Genetic mutations that lead to uncontrolled B-cell growth Previous treatments for other hematologic malignancies that may predispose to relapse Environmental exposures, such as certain chemicals or radiation, which are not directly linked but may contribute to disease development Age-related changes in immune function that can influence disease progression Unknown factors, as the precise cause of prolymphocytic leukemia remains unclear

Key Symptoms: Fatigue and weakness due to anemia Unintentional weight loss Swollen lymph nodes, especially in the neck, armpits, or groin Frequent infections because of compromised immune function Night sweats and fever Abdominal discomfort or fullness from an enlarged spleen or liver Easy bruising or bleeding owing to low platelet counts

Diagnosis Path: Complete blood count (CBC): To assess levels of different blood cells and look for abnormal lymphocytes Peripheral blood smear: Microscopic examination of blood cells to detect abnormal B-lymphocytes Bone marrow biopsy: To evaluate the extent of infiltration by malignant cells Flow cytometry: To identify specific cell surface markers characteristic of B-cell leukemia Cytogenetic and molecular testing: To detect genetic abnormalities associated with disease progression Lymph node or organ biopsies: If palpable or imaging suggests enlarged lymph nodes or spleen

Treatment Protocols: Chemotherapy: Using drugs to destroy cancerous B-cells, often with agents effective against leukemia Targeted therapy: Medications designed to target specific molecules involved in B-cell proliferation and survival Monoclonal antibody therapy: Such as rituximab, which can bind to B-cell surface markers and help destroy malignant cells Stem cell transplantation: In select cases, especially younger patients, to replace diseased bone marrow with healthy stem cells Supportive care: Including transfusions, antibiotics for infections, and treatments for symptoms and side effects